Cas:866546-10-3 3-bromo-5-chloro-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine manufacturer & supplier

Chemical Name:3-bromo-5-chloro-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine

CAS.NO:866546-10-3

Synonyms:3-bromo-5-chloro-1-tosyl-1H-pyrrolo[2,3-b]pyridine;3-bromo-5-chloro-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine;1H-Pyrrolo[2,3-b]pyridine,3-bromo-5-chloro-1-[(4-methylphenyl)sulfonyl]

Molecular Formula:C₁₄H₁₀BrClN₂O₂S

Molecular Weight:385.66300

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:527ºC at 760 mmHg

Density:1.68g/cm3

Index of Refraction:1.695

PSA:60.34000

Exact Mass:383.93300

LogP:5.07840

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-bromo-5-chloro-1-tosyl-1H-pyrrolo[2,3-b]pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrrolo[2,3-b]pyridine,3-bromo-5-chloro-1-[(4-methylphenyl)sulfonyl] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-bromo-5-chloro-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine Use and application,3-bromo-5-chloro-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine technical grade,usp/ep/jp grade.

Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. 3-bromo-5-chloro-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine manufacturer For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.” 3-bromo-5-chloro-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine supplier We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. 3-bromo-5-chloro-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine vendor New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country. 3-bromo-5-chloro-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine factory For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.”